Algo version: 0.98b
Medeon Biodesign Inc is listed at the TWO Exchange
Medeon Biodesign Inc [6499.TWO]
TWO Sector: Healthcare Industry:Medical Instruments Supplies

Is Medeon Biodesign Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Medeon Biodesign Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Wednesday 23rd of August 2023 were paid TWD0.49993 per share. Over the last 2 times between 2022 and 2023, Medeon Biodesign Inc has paid TWD1.45232 with an average of TWD0.73 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Medeon Biodesign Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD45.82, you would have made a loss of TWD-2.52 per share or -5.50%

Yes, the average daily trading liquidity for Medeon Biodesign Inc is TWD69 200 thousand. You should therefore be able to get in and out of your positions relatively fast.

Medeon Biodesign Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Medeon Biodesign Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.